These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8874152)

  • 1. Adrenaline release by the 5-HT1A receptor agonist 8-OH-DPAT is partly responsible for pituitary activation.
    Korte SM; Buwalda B; De Kloet ER; Bohus B
    Eur J Pharmacol; 1996 Aug; 309(3):281-6. PubMed ID: 8874152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat.
    Calogero AE; Bagdy G; Szemeredi K; Tartaglia ME; Gold PW; Chrousos GP
    Endocrinology; 1990 Apr; 126(4):1888-94. PubMed ID: 2156670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that 5-HT1A receptors are involved in the adrenaline-releasing effects of 8-OH-DPAT in the conscious rat.
    Chaouloff F; Baudrie V; Laude D
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Apr; 341(4):381-4. PubMed ID: 1970616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Socially defeated male rats display a blunted adrenocortical response to a low dose of 8-OH-DPAT.
    Korte SM; Buwalda B; Meijer O; De Kloet ER; Bohus B
    Eur J Pharmacol; 1995 Jan; 272(1):45-50. PubMed ID: 7713148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular and adrenaline-releasing effects of the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin in streptozotocin diabetic rats.
    Chaouloff F; Blanc J; Baudrie V; Laude D; Elghozi JL
    Life Sci; 1991; 48(26):2543-52. PubMed ID: 1828521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentobarbital anaesthesia prevents the adrenaline-releasing effect of the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino) tetralin.
    Chaouloff F; Baudrie V; Laude D
    Eur J Pharmacol; 1990 May; 180(1):175-8. PubMed ID: 2142092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WAY-100635 inhibits 8-OH-DPAT-stimulated oxytocin, ACTH and corticosterone, but not prolactin secretion.
    Vicentic A; Li Q; Battaglia G; Van de Kar LD
    Eur J Pharmacol; 1998 Apr; 346(2-3):261-6. PubMed ID: 9652368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated treatment with the 5-HT1A receptor agonist, ipsapirone, does not affect 8-OH-DPAT- and stress-induced increases in plasma adrenaline levels in the rat.
    Baudrie V; Chaouloff F
    Eur J Pharmacol; 1991 Jun; 198(2-3):129-35. PubMed ID: 1830845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of the anxiolytic-like action of ipsapirone and buspirone, but not that of 8-OH-DPAT, by adrenalectomy in male rats.
    López-Rubalcava C; Cruz SL; Fernández-Guasti A
    Psychoneuroendocrinology; 1999 May; 24(4):409-22. PubMed ID: 10341368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin directly stimulates cortisol secretion from the interrenals in goldfish.
    Lim JE; Porteus CS; Bernier NJ
    Gen Comp Endocrinol; 2013 Oct; 192():246-55. PubMed ID: 24013027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of 8-OH-DPAT-induced elevation of plasma corticotrophin by the 5-HT1A receptor antagonist WAY100635.
    Critchley DJ; Childs KJ; Middlefell VC; Dourish CT
    Eur J Pharmacol; 1994 Oct; 264(1):95-7. PubMed ID: 7828650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ganglionic transmission is a prerequisite for the adrenaline-releasing and hyperglycemic effects of 8-OH-DPAT.
    Chaouloff F; Laude D; Baudrie V
    Eur J Pharmacol; 1990 Aug; 185(1):11-8. PubMed ID: 2171956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen reduces serotonin-1A receptor-mediated oxytocin release and Galpha(i/o/z) proteins in the hypothalamus of ovariectomized rats.
    D'Souza DN; Zhang Y; Damjanoska KJ; Carrasco GA; Sullivan NR; Garcia F; Battaglia G; Doncarlos LL; Muma NA; Van de Kar LD
    Neuroendocrinology; 2004; 80(1):31-41. PubMed ID: 15385710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin.
    Schreiber R; Brocco M; Lefèbvre de Ladonchamps B; Monneyron S; Millan MJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):822-31. PubMed ID: 7473172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that 5-HT2 receptors mediate the pressor effect of 8-OH-DPAT in the spinally pithed rat.
    Deckert V; Chaouloff F; Richer C; Elghozi JL
    Arch Int Pharmacodyn Ther; 1990; 306():114-29. PubMed ID: 1981665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in 8-hydroxy-2-(dipropylamino)tetralin-induced neuroendocrine responses after 5,7-dihydroxytryptamine-induced denervation of serotonergic neurons.
    Van de Kar LD; Li Q; Cabrera TM; Brownfield MS; Battaglia G
    J Pharmacol Exp Ther; 1998 Jul; 286(1):256-62. PubMed ID: 9655867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
    Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of clozapine and 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on progressive ratio schedule performance: evidence against the involvement of 5-HT1A receptors in the behavioural effects of clozapine.
    Zhang Z; Rickard JF; Body S; Asgari K; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 2005 Sep; 181(2):381-91. PubMed ID: 15830225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential receptor reserve for 5-HT1A receptor-mediated regulation of plasma neuroendocrine hormones.
    Meller E; Bohmaker K
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1246-52. PubMed ID: 7996433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the adrenal gland in the metabolic and cardiovascular effects of 8-OH-DPAT in the rat.
    Bouhelal R; Mir AK
    Eur J Pharmacol; 1990 May; 181(1-2):89-95. PubMed ID: 2143731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.